Millendo Therapeutics Inc (MLND) Stock Analyst Ratings
USA - NASDAQ:MLND -
1.06
-0.06 (-5.36%)
1.06
0 (0%)
Analysts have set a mean price target forecast of 2.04. This target is 92.45% above the current price.
MLND is currently not analyzed by any analysts.